Clinical Trial Update: Plasma Neutrophil Gelatinase-associated Lipocalin (NGAL) as Early Biomarker for Renal Dysfunction and Good Neurologic Outcome in Out of Hospital Cardiac Arrest Patients

View source ↗

Summary

This clinical trial update discusses evaluating plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for renal dysfunction and favorab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Kidney Injury

Snippet

Sponsor: Yonsei University | Conditions: Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol | Status: UNKNOWN